Updated on 6 June 2014
The cloud-based solution will help firms in avoiding investing in and managing expensive IT infrastructure for clinical trials
Singapore: India's second largest IT firm Infosys has unveiled a cloud-based solution to speed up clinical trials and lower drug development costs at the three-day 'Sapphire Now' conference being held at Orlando, USA.
"The solution helps life sciences companies to accelerate clinical trials by driving greater collaboration between pharmaceutical firms and contract research organizations," the company said in its statement.
In the new version of clinical trial supply management, the cloud solution will improve productivity of drug development process and ensure timely supply of drugs to patients at lower cost.
"Enterprises using our solution will be able to price their drugs competitively as the software application enables real-time collaboration and helps transform their research and development (R&D) cost model," said Mr Manish Tandon, Infosys' global head for life sciences and services.
The solution offers tools to manage the entire supply chain of clinical trials, covering demand and supply, planning and distribution across R&D sites. A beta version of the solution is in use for clinical trials at some of the global pharma firms in Europe and USA.